Does ELTROMBOPAG Cause Product use in unapproved indication? 303 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 303 reports of Product use in unapproved indication have been filed in association with ELTROMBOPAG. This represents 5.5% of all adverse event reports for ELTROMBOPAG.
303
Reports of Product use in unapproved indication with ELTROMBOPAG
5.5%
of all ELTROMBOPAG reports
70
Deaths
69
Hospitalizations
How Dangerous Is Product use in unapproved indication From ELTROMBOPAG?
Of the 303 reports, 70 (23.1%) resulted in death, 69 (22.8%) required hospitalization, and 16 (5.3%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG. However, 303 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG Cause?
Platelet count decreased (968)
Death (629)
Drug ineffective (554)
Thrombocytopenia (262)
Off label use (255)
Headache (229)
Pyrexia (229)
Haemoglobin decreased (213)
Pneumonia (204)
Platelet count increased (186)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which ELTROMBOPAG Alternatives Have Lower Product use in unapproved indication Risk?
ELTROMBOPAG vs ELTROMBOPAG OLAMINE
ELTROMBOPAG vs ELUXADOLINE
ELTROMBOPAG vs ELVITEGRAVIR
ELTROMBOPAG vs EMAPALUMAB
ELTROMBOPAG vs EMAPALUMAB-LZSG